Alberto Terrón

441 total citations
21 papers, 252 citations indexed

About

Alberto Terrón is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Alberto Terrón has authored 21 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Virology and 6 papers in Hepatology. Recurrent topics in Alberto Terrón's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (6 papers). Alberto Terrón is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (6 papers). Alberto Terrón collaborates with scholars based in Spain and Italy. Alberto Terrón's co-authors include Ana Arizcorreta, J.A. Girón González, Patrizia Cristofori, G. Gaviraghi, F Brun, Guillermo Reglero, Tiziana Fornari, Carlos F. Torres, Fernando Lozano and Pompeyo Viciana and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Food Research International.

In The Last Decade

Alberto Terrón

20 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Terrón Spain 10 90 82 74 62 41 21 252
Li Wei China 11 42 0.5× 93 1.1× 26 0.4× 15 0.2× 17 0.4× 19 281
Elgin Green United States 6 224 2.5× 74 0.9× 31 0.4× 111 1.8× 127 3.1× 9 378
Ilaria Caramma Italy 10 107 1.2× 129 1.6× 87 1.2× 92 1.5× 17 0.4× 14 245
Joris Vandenbossche United States 9 55 0.6× 228 2.8× 211 2.9× 7 0.1× 21 0.5× 29 345
Ivan Schietroma Italy 12 96 1.1× 73 0.9× 36 0.5× 138 2.2× 77 1.9× 12 347
Emma Recio‐Fernández Spain 10 124 1.4× 58 0.7× 16 0.2× 47 0.8× 68 1.7× 16 272
Andrés Esteban-Cantos Spain 10 88 1.0× 88 1.1× 10 0.1× 100 1.6× 92 2.2× 14 253
Guglielmo Marco Migliorino Italy 10 106 1.2× 50 0.6× 14 0.2× 56 0.9× 34 0.8× 20 201
Giuseppe Barbaro Italy 8 62 0.7× 261 3.2× 245 3.3× 31 0.5× 54 1.3× 9 356
Natali Vega‐Magaña Mexico 12 170 1.9× 61 0.7× 16 0.2× 12 0.2× 20 0.5× 35 406

Countries citing papers authored by Alberto Terrón

Since Specialization
Citations

This map shows the geographic impact of Alberto Terrón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Terrón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Terrón more than expected).

Fields of papers citing papers by Alberto Terrón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Terrón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Terrón. The network helps show where Alberto Terrón may publish in the future.

Co-authorship network of co-authors of Alberto Terrón

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Terrón. A scholar is included among the top collaborators of Alberto Terrón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Terrón. Alberto Terrón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vivancos, María Jesús, David Vinuesa García, Antonio Collado, et al.. (2025). Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial. PLoS ONE. 20(9). e0323167–e0323167.
2.
Hidalgo‐Tenorio, Carmen, María Jesús Vivancos, David Vinuesa García, et al.. (2024). Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial. International Journal of Antimicrobial Agents. 63(6). 107164–107164. 6 indexed citations
3.
Hidalgo‐Tenorio, Carmen, Juan Pasquau, David Vinuesa, et al.. (2022). DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks). Viruses. 14(3). 524–524. 16 indexed citations
4.
Saumoy, María, Josep M. Llibre, Alberto Terrón, et al.. (2016). Short Communication: Maraviroc Once-Daily: Experience in Routine Clinical Practice. AIDS Research and Human Retroviruses. 33(1). 29–32. 4 indexed citations
5.
Pasquau, Juan, Luís F. López‐Cortés, Pompeyo Viciana, et al.. (2014). Monotherapy with darunavir/ritonavir is effective and safe in clinical practice. Journal of the International AIDS Society. 17(4S3). 19813–19813. 7 indexed citations
6.
Valero, Ignacio, Juan Pasquau, Rafael Rubio, et al.. (2014). CNS safety at 48‐week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV‐suppressed patients on stable ART: the SALT neurocognitive sub‐study. Journal of the International AIDS Society. 17(4S3). 19656–19656. 5 indexed citations
7.
8.
Labarga, Pablo, Pablo Barreiro, Josep M. Guardiola, et al.. (2012). Comparison of High Ribavirin Induction Versus Standard Ribavirin Dosing, Plus Peginterferon-  for the Treatment of Chronic Hepatitis C in HIV-Infected Patients: The PERICO Trial. The Journal of Infectious Diseases. 206(6). 961–968. 15 indexed citations
9.
Márquez-Coello, Mercedes, María José Soto‐Méndez, Claudio Rodríguez-Ramos, et al.. (2011). Bacterial Translocation in HIV-Infected Patients With HCV Cirrhosis: Implication in Hemodynamic Alterations and Mortality. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(5). 420–427. 26 indexed citations
10.
López‐Cortés, Luís F., Pompeyo Viciana, Rosa Ruiz-Valderas, et al.. (2010). Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study. AIDS Research and Therapy. 7(1). 5–5. 4 indexed citations
11.
Domingo, Peré, Ramón Teira, Fernando Lozano, et al.. (2008). Dyslipidemia and Cardiovascular Disease Risk Factor Management in HIV-1-Infected Subjects Treated with HAART in the Spanish VACH Cohort. The Open AIDS Journal. 2(1). 26–38. 21 indexed citations
12.
Gutiérrez‐Valencia, Alicia, Rosa Ruiz-Valderas, Luís Jiménez, et al.. (2008). Role of Pegylated Interferon-α-2a and Ribavirin Concentrations in Sustained Viral Response in HCV/HIV-Coinfected Patients. Clinical Pharmacology & Therapeutics. 84(5). 573–580. 15 indexed citations
13.
Mallolas, Josep, Pablo Labarga, Antonio Ocampo, et al.. (2007). Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir‐boosted saquinavir. The CIVSA Study*. HIV Medicine. 8(4). 226–233. 8 indexed citations
14.
González, J.A. Girón, et al.. (2007). Natural History of Compensated and Decompensated HCV-Related Cirrhosis in HIV-Infected Patients: A Prospective Multicentre Study. Antiviral Therapy. 12(6). 899–908. 30 indexed citations
15.
Teira, Ramón, Ignacio Suárez-Lozano, Pompeyo Viciana, et al.. (2005). Patrón epidemiológico de la infección por el VIH en 15 hospitales españoles: casos de nuevo diagnóstico incluidos en la cohorte VACH en 2001 y 2002. Enfermedades Infecciosas y Microbiología Clínica. 23(4). 213–217. 9 indexed citations
16.
Mira, José Antonio López, Fernando Lozano, Jesús Santos, et al.. (2004). Gynaecomastia in HIV-Infected Men on Highly Active Antiretroviral Therapy: Association with Efavirenz and Didanosine Treatment. Antiviral Therapy. 9(4). 511–517. 28 indexed citations
17.
Cristofori, Patrizia, et al.. (1994). Protective action of lacidipine in cardiac hypertrophy of the spontaneously hypertensive stroke-prone rat: an ultrastructural study.. PubMed. 26(3). 331–40. 5 indexed citations
18.
Cristofori, Patrizia, et al.. (1994). Lacidipine. Journal of Cardiovascular Pharmacology. 23. S90–S93. 10 indexed citations
19.
Gaviraghi, G., et al.. (1991). Lacidipine: Prevention of Vascular Damage Induced by Hypertension. Journal of Cardiovascular Pharmacology. 18. S7–S12. 8 indexed citations
20.
Cristofori, Patrizia, et al.. (1991). Vascular Protection of Lacidipine in Salt-Loaded Dahl-S Rats at Nonsustained Antihypertensive Doses. Journal of Cardiovascular Pharmacology. 17. S75–86. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li Wei Breakdown of academic impact, for papers by Elgin Green Breakdown of academic impact, for papers by Ilaria Caramma Breakdown of academic impact, for papers by Joris Vandenbossche Breakdown of academic impact, for papers by Ivan Schietroma Breakdown of academic impact, for papers by Emma Recio‐Fernández Breakdown of academic impact, for papers by Andrés Esteban-Cantos Breakdown of academic impact, for papers by Guglielmo Marco Migliorino Breakdown of academic impact, for papers by Giuseppe Barbaro Breakdown of academic impact, for papers by Natali Vega‐Magaña
Rankless by CCL
2026